Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis

Published:2018-05-14 Issue:10 Volume:23 Page:778-784
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Arbab Jafari Pourya¹,Ayatollahi Hossein¹,Sadeghi Ramin²,Sheikhi Maryam³,Asghari Amir⁴

Affiliation:

1. Department of Hematology and Blood Banking, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2. Department of Nuclear Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3. Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

4. Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10245332.2018.1471794

Reference27 articles.

1. Myelodysplastic Syndromes

2. Myelodysplastic syndromes: molecular pathogenesis and genomic changes

3. The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes

4. The World Health Organization (WHO) classification of the myeloid neoplasms

5. Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological relevance of alternative splicing in hematologic malignancies;Molecular Medicine;2024-05-17

2. Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing;Drug Discovery Today;2023-09

3. Towards understandings of serine/arginine-rich splicing factors;Acta Pharmaceutica Sinica B;2023-08

4. Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes;Hematology;2023-02-23

5. Prognostic Indicators in MDS and CMML;Pathogenesis and Treatment of Leukemia;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3